Senior QA Officer - FTC

At OXB, our people are at the heart of everything we do. We’re on a mission to enable life‑changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day:
Responsible, Responsive, Resilient, and Respectful

We’re currently recruiting for a Senior Quality Assurance Officer to join our Quality Assurance team on a 12 month fixed‑term contract
. In this role, you will provide expert QA support for OXB Manufacturing Operations, playing a key part in advancing our mission and making a real difference.

Please note, this role will be 5 days a week onsite at our Cowley and Yarnton facilities.

• Reviewing and approving deviations, CAPAs and change controls within defined timelines.
• Supporting manufacturing teams as a QA partner to ensure GMP compliance during production activities.
• Reviewing batch documentation and supporting preparation for Qualified Person batch disposition.
• Participating in investigations, root cause analysis and risk assessments for quality events.
• Reviewing and approving SOPs, protocols, reports and other GMP documentation.
• Supporting implementation of new manufacturing processes for incoming client programs.
• Contributing to continuous improvement initiatives to strengthen quality systems and operational processes.

• Experience in a GMP‑regulated pharmaceutical, biotechnology or similar manufacturing environment.
• Significant experience managing quality events such as deviations, CAPAs and change controls.
• Strong understanding of GMP regulations and regulatory expectations (FDA / EMA).
• Ability to work independently, make sound quality decisions and manage multiple priorities.
• Strong communication skills and the ability to collaborate closely with manufacturing and technical teams.

OXB (LSE: OXB) is a global quality and innovation‑led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life‑changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno‑associated virus (AAV), adenovirus and other viral vector types.

OXB’s world‑class capabilities range from early‑stage development to commercialisation. These capabilities are supported by robust quality‑assurance systems, analytical methods and depth of regulatory expertise.

OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the Tetra Vecta™ system), a dual‑plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.

OXB, a FTSE
250 and FTSE4

Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.

• Wellbeing programs that support your mental and physical health
• Career development opportunities to help you grow and thrive
• Supportive, inclusive, and collaborative culture
• State‑of‑the‑art labs and manufacturing facilities
• A company that lives its values:
  Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB we’re future‑focused and growing fast. We succeed together—through passion, commitment, and teamwork.